Polypharmacology – Foe or Friend? von Peters, Jens-Uwe

Volltext

Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche Compounds von Peters, Jens-Uwe, Schnider, Patrick, Mattei, Patrizio, Kansy, Manfred

Volltext

Details Matter in Structure-based Drug Design von Kuhn, Bernd, Peters, Jens-Uwe, Rudolph, Markus G, Mohr, Peter, Stahl, Martin, Tosstorff, Andreas

Volltext

Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators: Discovery of 2‑Chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl‑1H‑imidazol-4-ylethynyl]pyridine (Basimglurant, RO4917523... von Jaeschke, Georg, Kolczewski, Sabine, Spooren, Will, Vieira, Eric, Bitter-Stoll, Nadia, Boissin, Patrick, Borroni, Edilio, Büttelmann, Bernd, Ceccarelli, Simona, Clemann, Nicole, David, Beatrice, Funk, Christoph, Guba, Wolfgang, Harrison, Anthony, Hartung, Thomas, Honer, Michael, Huwyler, Jörg, Kuratli, Martin, Niederhauser, Urs, Pähler, Axel, Peters, Jens-Uwe, Petersen, Ann, Prinssen, Eric, Ricci, Antonio, Rueher, Daniel, Rueher, Marianne, Schneider, Manfred, Spurr, Paul, Stoll, Theodor, Tännler, Daniel, Wichmann, Jürgen, Porter, Richard H, Wettstein, Joseph G, Lindemann, Lothar

Volltext

Safety screening in early drug discovery: An optimized assay panel von Bendels, Stefanie, Bissantz, Caterina, Fasching, Bernhard, Gerebtzoff, Grégori, Guba, Wolfgang, Kansy, Manfred, Migeon, Jacques, Mohr, Susanne, Peters, Jens-Uwe, Tillier, Fabien, Wyler, René, Lerner, Christian, Kramer, Christian, Richter, Hans, Roberts, Sonia

Volltext

Can we discover pharmacological promiscuity early in the drug discovery process? von Peters, Jens-Uwe, Hert, Jérôme, Bissantz, Caterina, Hillebrecht, Alexander, Gerebtzoff, Grégori, Bendels, Stefanie, Tillier, Fabien, Migeon, Jacques, Fischer, Holger, Guba, Wolfgang, Kansy, Manfred

Volltext

Synthesis of potential drug metabolites by a modified Udenfriend reaction von Slavik, Roger, Peters, Jens-Uwe, Giger, Rudolf, Bürkler, Markus, Bald, Eric

Volltext

Metabolite Identification via LC-SPE-NMR-MS of the In vitro Biooxidation Products of a Lead mGlu5 Allosteric Antagonist and Impact on the Improvement of Metabolic Stability in the... von Ceccarelli, Simona M., Schlotterbeck, Götz, Boissin, Patrick, Binder, Martin, Buettelmann, Bernd, Hanlon, Steven, Jaeschke, Georg, Kolczewski, Sabine, Kupfer, Ernst, Peters, Jens-Uwe, Porter, Richard H. P., Prinssen, Eric P., Rueher, Marianne, Ruf, Iris, Spooren, Will, Stämpfli, Andreas, Vieira, Eric

Volltext

Tyramine fragment binding to BACE-1 von Kuglstatter, Andreas, Stahl, Martin, Peters, Jens-Uwe, Huber, Walter, Stihle, Martine, Schlatter, Daniel, Benz, Jörg, Ruf, Armin, Roth, Doris, Enderle, Thilo, Hennig, Michael

Volltext

Synthesis of [3H]fenobam, a radioligand for the mGlu5 receptor von Hartung, Thomas, Peters, Jens-Uwe, Wichmann, Jürgen, Hubschwerlen, Christian, Jaeschke, Georg

Volltext

Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands : Optimising brain penetration von PETERS, Jens-Uwe, LÜBBERS, Thomas, ALANINE, Alexander, KOLCZEWSKI, Sabine, BLASCO, Francesca, STEWARD, Lucinda

Volltext

Novel orally active, dibenzazepinone-based γ-secretase inhibitors von Peters, Jens-Uwe, Galley, Guido, Jacobsen, Helmut, Czech, Christian, David-Pierson, Pascale, Kitas, Eric A., Ozmen, Laurence

Volltext

1,3-Disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitors von Lübbers, Thomas, Böhringer, Markus, Gobbi, Luca, Hennig, Michael, Hunziker, Daniel, Kuhn, Bernd, Löffler, Bernd, Mattei, Patrizio, Narquizian, Robert, Peters, Jens-Uwe, Ruff, Yves, Wessel, Hans Peter, Wyss, Pierre

Volltext

Lead Generation: Sowing the Seeds for Future Success von Bleicher, Konrad H., Nettekoven, Matthias, Peters, Jens-Uwe, Wyler, René

Volltext

A facile Horner–Wadsworth–Emmons route to 2-quinolones von Peters, Jens-Uwe, Capuano, Tony, Weber, Silja, Kritter, Stéphane, Sägesser, Matthias

Volltext

Discovery of potent, balanced and orally active dual NK1/NK3 receptor ligands von Peters, Jens-Uwe, Hoffmann, Torsten, Schnider, Patrick, Stadler, Heinz, Koblet, Andreas, Alker, André, Poli, Sonia Maria, Ballard, Theresa M., Spooren, Will, Steward, Lucinda, Sleight, Andrew J.

Volltext

Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands : Structure-activity relationship elucidation von PETERS, Jens-Uwe, LÜBBERS, Thomas, ALANINE, Alexander, KOLCZEWSKI, Sabine, BLASCO, Francesca, STEWARD, Lucinda

Volltext

Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: Optimization of in vitro activity von Peters, Jens-Uwe, Kühne, Holger, Dehmlow, Henrietta, Grether, Uwe, Conte, Aurelia, Hainzl, Dominik, Hertel, Cornelia, Kratochwil, Nicole A., Otteneder, Michael, Narquizian, Robert, Panousis, Constantinos G., Ricklin, Fabienne, Röver, Stephan

Volltext

Aminomethylpyrimidines as novel DPP-IV inhibitors: a 10(5)-fold activity increase by optimization of aromatic substituents von Peters, Jens-Uwe, Weber, Silja, Kritter, Stéphane, Weiss, Peter, Wallier, Angelina, Boehringer, Markus, Hennig, Michael, Kuhn, Bernd, Loeffler, Bernd-Michael

Volltext

Rational design, synthesis, and structure–activity relationship of benzoxazolones: New potent mglu5 receptor antagonists based on the fenobam structure von Ceccarelli, Simona M., Jaeschke, Georg, Buettelmann, Bernd, Huwyler, Jörg, Kolczewski, Sabine, Peters, Jens-Uwe, Prinssen, Eric, Porter, Richard, Spooren, Will, Vieira, Eric

Volltext